Please login to access the content

Forgot password?

New user


Adaptive e-learning programme to provide dermatologists working in the clinical management of atopic dermatitis with evidence-based learning to better understand and manage moderate to severe atopic dermatitis in children.

The programme offers information on the burden in children and adolescents, and provides improved diagnosis, assessment and management tools. Practical tips, patient perspectives and clinical case scenarios are also found in an interactive case study module, to put your skills to the test.

What you will learn:

  • Module 1. The scale of the problem: Review the burden of atopic dermatitis in Europe
  • Module 2. The impact on mental health: Focus on mental health in children and adolescents with moderate-to-severe atopic dermatitis
  • Module 3. Improving diagnosis, assessment and management: Recognise that atopic dermatitis is under-diagnosed and under-treated in Europe
  • Module 4.  Put knowledge into practice: Practical tips, patient perspective, and case scenarios

Take the Post test

CME Accreditation

Accredited by EACCME

This course, organized by Infomedica (International) Limited, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM.

Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

This programme is supported by Sanofi and Regeneron Pharmaceuticals 

Who is this course for?  

This activity is designed for dermatologists. Other healthcare professionals who diagnose, treat, and/or manage people with atopic dermatitis may also benefit from this course.

How to claim your credits

Complete the course (all modules) and click on the final button to submit your results. Your CME certificate will be available in the “My Tests” section of your profile.

What is adaptive learning?

An online delivery method that automatically adjusts to the needs of each learner, and recreates at scale the optimal teaching approach of a one-on-one personal tutor.
Adaptive learning technology uses proven data analytics and intelligent technologies to adjust in real-time to deliver an optimal experience

Conflict of Interest Statement

Infomedica pays special attention to issues of independence and potential bias to maintain the integrity of its educational programmes. All individuals in a position to influence the contents of this programme have disclosed any financial relationship with organizations. Infomedica has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.

Prof. Jacob Thyssen discloses the following

Receipt of grants/research supports: Pfizer, Regeneron, and Sanofi-Genzyme.
Receipt of honoraria or consultation fees: AbbVie, Almirall, Arena Pharmaceuticals, Coloplast, OM Pharma, Aslan Pharmaceuticals, Union Therapeutics, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme.
Stock shareholder: AbbVie, Almirall, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme.


The views and opinions expressed in this activity are those of the faculty.

Special thanks

We would like to express our gratitude to the following scientific societies for helping us share this programme.
Please note that the views and opinions expressed in this programme may not reflect the official policies or positions of these societies.